To be a shareholder - you have to have a thick skin - if it
To be a shareholder - you have to have a thick skin - if it is not the bashers giving you neg comments on this small stock, it the biggest shareholders giving you bs on this small stock - seem to get negativity from all directions; As a long term shareholder, I still believe in Mgmt - maybe not some large shareholders tho in this stock. this is the type of thing I see all the time when I enter my brokerage account on DECN - Alert Triggered for Decision Diagnostics Corp
DECN is down $0.01 or 12.50% to $0.07 on heavy volume that exceeded its daily average by +82.87%. This performance is worse than the broader averages as the S&P 500 is down -0.19% on the day.
Please note you will receive only one "Trading Volume Exceeds Daily Average" alert per day for Decision Diagnostics Corp. - thanks to my brokerage for only sending this once per day. lol GLA IMO - think 2019 at this point
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...
Continue Reading
BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...
Continue Reading
NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...
Continue Reading
Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...
Continue Reading
Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...
Continue Reading
